NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 289 filers reported holding NATERA INC in Q3 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,872 | -14.2% | 64,904 | -5.7% | 0.14% | -7.5% |
| Q2 2023 | $3,349 | +42.5% | 68,829 | +62.5% | 0.15% | +31.5% |
| Q1 2023 | $2,351 | +1.0% | 42,349 | -26.9% | 0.11% | -14.0% |
| Q4 2022 | $2,327 | -99.9% | 57,919 | -4.2% | 0.13% | -19.4% |
| Q3 2022 | $2,648,000 | +49.9% | 60,440 | +21.3% | 0.16% | +20.3% |
| Q2 2022 | $1,766,000 | +81.1% | 49,840 | +108.0% | 0.13% | +107.8% |
| Q1 2022 | $975,000 | +14.2% | 23,961 | +162.0% | 0.06% | -40.2% |
| Q4 2021 | $854,000 | -16.2% | 9,145 | 0.0% | 0.11% | -21.3% |
| Q3 2021 | $1,019,000 | -49.9% | 9,145 | -67.5% | 0.14% | -78.9% |
| Q3 2020 | $2,032,000 | +19.2% | 28,124 | -17.7% | 0.64% | +11.4% |
| Q2 2020 | $1,704,000 | +232.8% | 34,175 | +99.2% | 0.58% | +168.1% |
| Q1 2020 | $512,000 | -16.2% | 17,160 | -5.4% | 0.22% | +18.7% |
| Q4 2019 | $611,000 | -27.6% | 18,132 | -29.5% | 0.18% | -42.2% |
| Q3 2019 | $844,000 | +170.5% | 25,732 | +127.4% | 0.32% | +173.9% |
| Q2 2019 | $312,000 | -63.8% | 11,318 | -68.5% | 0.12% | -38.2% |
| Q3 2018 | $861,000 | – | 35,967 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |